Oaktree Acquisition Corp. III Life Sciences (OACC) stock
OACCNasdaqBlank ChecksFiscal year ends December 31Also trades as OACCU, OACCW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026
$10.72+0.02 (+0.19%)
Close on Nov 17, 2026Market cap $263.53MP/E –Yield –
Oaktree Acquisition Corp. III Life Sciences operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Oaktree Acquisition Corp. III Life Sciences's operating cash flow for the twelve months ending Jun 30, 2026 was -$455.69K. For fiscal 2025 it was -$422.08K.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$422.08K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$97.26K | – |
| Q1 FY2026 | Mar 31, 2026 | -$158.04K | – |
| Q4 FY2025 | Dec 31, 2025 | -$143.88K | – |
| Q3 FY2025 | Sep 30, 2025 | -$56.52K | – |
| Q2 FY2025 | Jun 30, 2025 | -$146.12K | – |
| Q1 FY2025 | Mar 31, 2025 | -$75.56K | – |
| Q3 FY2024 | Sep 30, 2024 | $0 | – |
See a number that looks wrong?